SinoFresh Nasal Spray To Be Evaluated In Initial H1N1 Animal Pilot Study To Assess Ability To Kill Or Reduce Virus Levels
SinoFresh Healthcare Products, Inc., has commissioned a study to evaluate the ability of SinoFresh Homeopathic Antiseptic Nasal Spray to significantly inhibit H1N1 Virus infection in live animal test subjects.

VENICE, FL, September 21, 2009 /24-7PressRelease/ -- David R. Olund, President of SinoFresh Healthcare Products, Inc., says, "the company is initiating this preliminary study in response to widespread concern over the continued spread of the H1N1 virus in the U.S. and Internationally. SinoFresh's topical antiseptic nasal spray has demonstrated in previous studies the ability to reduce the presence of a wide range of airborne pathogens in the nasal and sinus cavities and we believe that the product may have a favorable effect on the H1N1 virus. Our goal is that the SinoFresh product line will ultimately emerge as a cost effective consumer and institutional option for broad based airborne disease prevention."

Chief Medical advisor, Dr. Michael Stampar says "Our goal is to demonstrate that a topical antiseptic nasal spray can prevent infection, reduce severity or reduce the duration of viral shedding. Previously positive in-vitro and in-vivo studies that included a number of widely known airborne pathogens, as well as MRSA, give the Company reason to be optimistic in my opinion."

Press Release Contact Information:

David Olund
Sinofresh Healthcare Products
President
333 South Tamiami Trail, #286
Venice, FL
USA 34285
Voice: 888-460-4774
Fax: 888-460-4774
Website: Visit Our Website